M.J. Escudero

3.1k total citations
71 papers, 2.4k citations indexed

About

M.J. Escudero is a scholar working on Materials Chemistry, Electrical and Electronic Engineering and Electronic, Optical and Magnetic Materials. According to data from OpenAlex, M.J. Escudero has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Materials Chemistry, 20 papers in Electrical and Electronic Engineering and 19 papers in Electronic, Optical and Magnetic Materials. Recurrent topics in M.J. Escudero's work include Advancements in Solid Oxide Fuel Cells (42 papers), Electronic and Structural Properties of Oxides (22 papers) and Electrocatalysts for Energy Conversion (15 papers). M.J. Escudero is often cited by papers focused on Advancements in Solid Oxide Fuel Cells (42 papers), Electronic and Structural Properties of Oxides (22 papers) and Electrocatalysts for Energy Conversion (15 papers). M.J. Escudero collaborates with scholars based in Spain, Mexico and France. M.J. Escudero's co-authors include L. Daza, Ainara Aguadero, J. A. Alonso, A. Fuerte, Rita X. Valenzuela, Domingo Pérez-Coll, Esther Hontañón, M. T. Fernández‐Díaz, C. de la Calle and Carlos Bautista and has published in prestigious journals such as Journal of Clinical Oncology, Chemistry of Materials and Journal of Power Sources.

In The Last Decade

M.J. Escudero

70 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.J. Escudero Spain	27	1.7k	802	644	524	318	71	2.4k
Xinzhe Li China	37	1.4k 0.8×	448 0.6×	1.9k 2.9×	2.3k 4.3×	371 1.2×	97	4.1k
Piotr Jasiński Poland	28	2.6k 1.6×	698 0.9×	1.5k 2.3×	607 1.2×	445 1.4×	241	3.9k
Xirui Wang China	19	1.1k 0.7×	411 0.5×	573 0.9×	263 0.5×	107 0.3×	53	2.1k
Yongseon Kim South Korea	22	656 0.4×	324 0.4×	1.3k 2.0×	358 0.7×	141 0.4×	78	1.9k
Junyoung Kim South Korea	24	1.8k 1.1×	951 1.2×	736 1.1×	352 0.7×	225 0.7×	53	2.5k
Hiromu Watanabe Japan	19	1.1k 0.7×	179 0.2×	438 0.7×	171 0.3×	253 0.8×	65	1.9k
Xianbo Yu China	28	780 0.5×	614 0.8×	1.3k 2.1×	916 1.7×	85 0.3×	75	2.2k
Kun Zheng China	33	2.2k 1.3×	1.5k 1.8×	1.4k 2.1×	300 0.6×	140 0.4×	174	3.3k
Jie Tian China	27	579 0.3×	612 0.8×	1.2k 1.9×	264 0.5×	41 0.1×	78	2.6k
N. Maffei Canada	24	874 0.5×	250 0.3×	360 0.6×	154 0.3×	253 0.8×	64	1.6k

Countries citing papers authored by M.J. Escudero

Since Specialization

Citations

This map shows the geographic impact of M.J. Escudero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Escudero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Escudero more than expected).

Fields of papers citing papers by M.J. Escudero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Escudero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Escudero. The network helps show where M.J. Escudero may publish in the future.

Co-authorship network of co-authors of M.J. Escudero

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Escudero. A scholar is included among the top collaborators of M.J. Escudero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Escudero. M.J. Escudero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Escudero, M.J., et al.. (2025). Electrochemical performance of planar IT-SOFCs with lanthanum nickelate and double perovskite cathodes. Electrochimica Acta. 532. 146511–146511. 1 indexed citations

Escudero, M.J., et al.. (2024). Impact of electrical conductivity and the electrochemical performance of La2NiO4+δ and La4Ni3O10±δ cathodes on symmetric cells for intermediate-temperature SOFCs. Journal of Materials Science. 59(23). 10357–10372. 2 indexed citations

Escudero, M.J., et al.. (2020). Double perovskite La1.8Sr0.2CoFeO5+δ as a cathode material for intermediate temperature solid oxide fuel cells. Journal of Alloys and Compounds. 862. 158025–158025. 31 indexed citations

Ocaña, Alberto, Marta Gil-Martín, Silvia Antolín, et al.. (2019). Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study. Breast Cancer Research and Treatment. 174(3). 693–701. 36 indexed citations

Escudero, M.J., Eva Carrasco, Begoña Bermejo, et al.. (2019). Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project. Clinical & Translational Oncology. 21(12). 1746–1753. 1 indexed citations

Escudero, M.J., et al.. (2019). Individual impact of several impurities on the performance of direct internal reforming biogas solid oxide fuel cell using W-Ni-CeO2 as anode. International Journal of Hydrogen Energy. 44(36). 20616–20631. 20 indexed citations

Quiroga, Vanesa, Esther Holgado, José Luis Alonso-Romero, et al.. (2018). Run-in-phase results from a multicenter phase II trial to evaluate pembrolizumab (P) and gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 PANGEA-Breast. Annals of Oncology. 29. x32–x32. 1 indexed citations

Borrego, Manuel Ruíz, Marta Gil-Martín, Silvia Antolín, et al.. (2017). A phase II trial of dasatinib (D) in combination with trastuzumab (T) and paclitaxel (P) in the first line treatment of HER2 positive metastatic breast cancer (MBC) patients (pts): GEICAM/2010-04. Annals of Oncology. 28. v75–v75. 1 indexed citations

Santonja, Ángela, Joan Albanell, Alfonso Sánchez‐Muñoz, et al.. (2016). Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer. Annals of Oncology. 27. vi55–vi55.

10.

Martín, Miguel, Moshe Inbar, Eva Carrasco, et al.. (2015). Phase III study of Palbociclib in combination with Exemestane vs. Capecitabine, in Hormonal Receptor (HR) positive/HER2 negative Metastatic Breast Cancer (MBC) patients with Resistance to non-steroidal Aromatase inhibitors (NSAI): PEARL study (GEICAM/2013-02_CECOG/BC.1.3.006). Journal of Clinical Oncology. 1 indexed citations

11.

Escudero, M.J., et al.. (2015). Performance evaluation of WNi–CeO2 as anode in a solid oxide fuel cell fed by simulated biogas mixtures. International Journal of Hydrogen Energy. 40(34). 11303–11314. 10 indexed citations

12.

Quintela-Fandiño, Miguel, Ander Urruticoechea, Juan Antonio Guerra, et al.. (2014). Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study). British Journal of Cancer. 111(6). 1060–1064. 29 indexed citations

13.

Gállego, Javier, et al.. (2014). Colorectal Cancer Surgery in Extreme Elderly Population. Journal of Cancer Therapy. 6(1). 12–20. 1 indexed citations

14.

Alba, Emilio, José Ignacio Chacón, Aňa Lluch, et al.. (2012). A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study. Breast Cancer Research and Treatment. 136(2). 487–493. 101 indexed citations

15.

Martín, Miguel, Pedro Sánchez‐Rovira, Montserrat Muñoz-Mateu, et al.. (2011). Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004–05 study. Annals of Oncology. 22(12). 2591–2596. 26 indexed citations

16.

Alba, Emilio, José Ignacio Chacón, Aňa Lluch, et al.. (2011). Chemotherapy (CT) with or without carboplatin as neoadjuvant treatment in patients with basal-like breast cancer: GEICAM 2006-03—A multicenter, randomized phase II study.. Journal of Clinical Oncology. 29(15_suppl). 1015–1015. 9 indexed citations

17.

Escudero, M.J., A. Fuerte, & L. Daza. (2010). La2NiO4+δ potential cathode material on La0.9Sr0.1Ga0.8Mg0.2O2.85 electrolyte for intermediate temperature solid oxide fuel cell. Journal of Power Sources. 196(17). 7245–7250. 44 indexed citations

18.

Haba-Rodríguez, Juan de la, Álvaro Rodríguez-Lescure, Amparo Ruı́z, et al.. (2010). Regional and seasonal influence in patient’s toxicity to adjuvant chemotherapy for early breast cancer. Breast Cancer Research and Treatment. 125(1). 273–278. 5 indexed citations

19.

Martín, Miguel, Amparo Ruı́z, A. Balil, et al.. (2007). Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. The Lancet Oncology. 8(3). 219–225. 139 indexed citations

20.

Aguadero, Ainara, M.J. Escudero, M. Martínez Pérez, et al.. (2006). Effect of Sr content on the crystal structure and electrical properties of the system La_2−xSr_xNiO_4+δ(0 ≤ x ≤ 1). Dalton Transactions. 4377–4383. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact